Cephalon demands secret patent-settlement info

Cephalon asked a U.S. judge to order the Federal Trade Commission to release confidential documents on drug patent-litigation settlements throughout the pharma industry, saying it needs the documents defend against an FTC lawsuit that seeks to clear generic competition for the company's top-selling narcolepsy treatment Provigil. Report